Eli P. Darnell

601 total citations
10 papers, 406 citations indexed

About

Eli P. Darnell is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Eli P. Darnell has authored 10 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Physiology. Recurrent topics in Eli P. Darnell's work include CAR-T cell therapy research (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Sarcoidosis and Beryllium Toxicity Research (2 papers). Eli P. Darnell is often cited by papers focused on CAR-T cell therapy research (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Sarcoidosis and Beryllium Toxicity Research (2 papers). Eli P. Darnell collaborates with scholars based in United States and Israel. Eli P. Darnell's co-authors include Melis Yilmaz, Kerry L. Reynolds, Erez N. Baruch, Meghan J. Mooradian, Prescott G. Woodruff, Joris Ramstein, Laura L. Koth, Melissa Ho, Christine Nguyen and Misha R. Agarwal and has published in prestigious journals such as Nature Communications, European Respiratory Journal and The American Journal of Surgery.

In The Last Decade

Eli P. Darnell

6 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eli P. Darnell United States	6	258	167	96	93	60	10	406
Naoko Miyata Japan	10	106 0.4×	97 0.6×	23 0.2×	88 0.9×	57 0.9×	29	358
Richard Lemal France	11	139 0.5×	51 0.3×	94 1.0×	152 1.6×	67 1.1×	81	512
Parikshit Asutosh Khadaroo China	13	186 0.7×	233 1.4×	58 0.6×	41 0.4×	62 1.0×	18	549
Alyx Rosen United States	12	274 1.1×	70 0.4×	23 0.2×	43 0.5×	130 2.2×	19	507
Junhai Pan China	9	286 1.1×	276 1.7×	44 0.5×	68 0.7×	100 1.7×	23	532
Daniel Leino United States	7	123 0.5×	53 0.3×	22 0.2×	47 0.5×	50 0.8×	20	290
Naomi Konishi Japan	9	199 0.8×	108 0.6×	17 0.2×	44 0.5×	55 0.9×	24	364
M. Rossi Italy	11	239 0.9×	253 1.5×	51 0.5×	15 0.2×	72 1.2×	20	458
Takuma Isshiki Japan	14	36 0.1×	283 1.7×	160 1.7×	76 0.8×	75 1.3×	41	464
Georgios Ayiomamitis Greece	12	214 0.8×	92 0.6×	15 0.2×	62 0.7×	62 1.0×	22	411

Countries citing papers authored by Eli P. Darnell

Since Specialization

Citations

This map shows the geographic impact of Eli P. Darnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli P. Darnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli P. Darnell more than expected).

Fields of papers citing papers by Eli P. Darnell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli P. Darnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli P. Darnell. The network helps show where Eli P. Darnell may publish in the future.

Co-authorship network of co-authors of Eli P. Darnell

This figure shows the co-authorship network connecting the top 25 collaborators of Eli P. Darnell. A scholar is included among the top collaborators of Eli P. Darnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli P. Darnell. Eli P. Darnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Park, Sangwoo, Christine Ho, Eli P. Darnell, et al.. (2025). Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer. Nature Communications. 16(1). 11246–11246.

Soumerai, Jacob D., Lynn Huynh, Yichuan Grace Hsieh, et al.. (2024). IgG testing, immunoglobulin replacement therapy, and infection outcomes in patients with CLL or NHL: real-world evidence. Blood Advances. 8(16). 4239–4249. 6 indexed citations

Darnell, Eli P. & Marcela V. Maus. (2024). Context matters: Tumor microenvironments impact cellular therapy success. Cell Reports Medicine. 5(4). 101491–101491.

Camacho, Daniel F., Eli P. Darnell, Domenick E. Kennedy, et al.. (2022). IRF4 expression by lung dendritic cells drives acute but not Trm cell–dependent memory Th2 responses. JCI Insight. 7(21). 8 indexed citations

Maness, Patricia F., Eli P. Darnell, Galina P. Demyanenko, et al.. (2021). ALCAM Regulates Mediolateral Retinotopic Mapping in the Superior Colliculus. UNC Libraries.

Darnell, Eli P., Melissa Lumish, Yasmin G. Hernandez‐Barco, et al.. (2020). Preoperative cholangitis is an independent risk factor for mortality in patients after pancreatoduodenectomy for pancreatic cancer. The American Journal of Surgery. 221(1). 134–140. 14 indexed citations

Darnell, Eli P., Meghan J. Mooradian, Erez N. Baruch, Melis Yilmaz, & Kerry L. Reynolds. (2020). Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls. Current Oncology Reports. 22(4). 39–39. 267 indexed citations

Darnell, Eli P., et al.. (2020). IL-1Rahigh-IL-4low-IL-13low: A Novel Plasma Cytokine Signature Associated with Olfactory Dysfunction in Older US Adults. Chemical Senses. 45(5). 407–414.

Li, Michael, Nirav R. Bhakta, Owen D. Solberg, et al.. (2014). Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes. European Respiratory Journal. 44(4). 985–993. 47 indexed citations

10.

Agarwal, Misha R., Christine Nguyen, Joris Ramstein, et al.. (2013). Interferon-inducible chemokines reflect severity and progression in sarcoidosis. Respiratory Research. 14(1). 121–121. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact